IDEX Biometrics ASA
IDBA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,393,764 | $1,297,528 | $1,244,088 | $1,241,820 |
| - Cash | $1,086 | $2,064 | $3,002 | $11,384 |
| + Debt | $2,777 | $4,183 | $8,163 | $10,512 |
| Enterprise Value | $1,395,455 | $1,299,647 | $1,249,248 | $1,240,949 |
| Revenue | $61 | $386 | $356 | $510 |
| % Growth | -84.1% | 8.4% | -30.2% | – |
| Gross Profit | -$1,485 | $153 | -$3,253 | -$3,732 |
| % Margin | -2,423.3% | 39.5% | -912.9% | -731.2% |
| EBITDA | $1,616 | -$4,891 | -$4,234 | -$4,669 |
| % Margin | 2,638.3% | -1,266.2% | -1,188.2% | -914.9% |
| Net Income | $1,389 | -$6,691 | -$5,191 | -$5,262 |
| % Margin | 2,266.7% | -1,732.2% | -1,457% | -1,031% |
| EPS Diluted | 0.046 | -0.023 | -0.018 | -0.019 |
| % Growth | 305.7% | -23.9% | 2.9% | – |
| Operating Cash Flow | -$2,323 | -$5,057 | -$6,521 | -$4,133 |
| Capital Expenditures | $2,323 | $15 | -$14 | -$4 |
| Free Cash Flow | -$0 | -$5,042 | -$6,535 | -$4,136 |